Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: A systematic review and meta-analysis

BMJ (Online)

Volumn 350, Issue , 2015, Pages

  Balsells, Montserrat ^a   García Patterson, Apolonia ^b   Solà, Ivan ^b,c   Roqué, Marta ^b,c   Gich, Ignasi ^b,c,d   Corcoy, Rosa ^b,d,e  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; INSULIN; METFORMIN; ANTIDIABETIC AGENT;

BODY MASS; CONGENITAL MALFORMATION; DRUG TREATMENT FAILURE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HIGH BIRTH WEIGHT; HOSPITAL ADMISSION; HUMAN; HYPERINSULINISM; HYPOCALCEMIA; HYPOGLYCEMIA; JAUNDICE; LOW BIRTH WEIGHT; MACROSOMIA; MATERNAL HYPERTENSION; META ANALYSIS; NEWBORN MORTALITY; POLYCYTHEMIA; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; WEIGHT GAIN; ADULT; BIRTH WEIGHT; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; REGRESSION ANALYSIS;

ADULT; BIRTH WEIGHT; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; GLYBURIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INSULIN; METFORMIN; PREGNANCY; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS;

EID: 84921802321     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h102     Document Type: Review

References (38)

1. Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007;34:173-99.
2. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-8.
3. Lain KY, Garabedian MJ, Daftary A, Jeyabalan A. Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin. Am J Obstet Gynecol 2009;200:501.e501-506.
4. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358:2003-15.
5. Silva JC, Fachin DR, Coral ML, Bertini AM. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus. J Perinat Med 2012;40:225-8.
6. Jacobson GF, Ramos GA, Ching JY, Kirby RS, Ferrara A, Field DR. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 2005;193:118-24.
7. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30(suppl 2):S251-60.
8. National Institute for Health and Care Excellence. Diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period. (Clinical guideline 63.) 2008. www.nice.org.uk/guidance/cg63/.
9. Committee on Practice Bulletins - Obstetrics. Practice bulletin No. 137: gestational diabetes mellitus. Obstet Gynecol 2013;122:406-16.
10. Coetzee EJ. Pregnancy and diabetes scenario around the world: Africa. Int J Gynaecol Obstet 2009;104:S39-41.
11. Goh JE, Sadler L, Rowan J. Metformin for gestational diabetes in routine clinical practice. Diabetic Med 2011;28:1082-7.
12. Camelo Castillo W, Boggess K, Sturmer T, Brookhart MA, Benjamin DK Jr, Jonsson Funk M. Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. Obstet Gynecol 2014;123:1177-84.
13. Heilmaier C, Thielscher C, Ziller M, Altmann V, Kostev K. Use of antidiabetic agents in the treatment of gestational diabetes mellitus in Germany, 2008-2012. J Obstet Gynaecol Res 2014;40:1592-7.
14. Moretti ME, Rezvani M, Koren G. Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes. Ann Pharmacother 2008;42:483-90.
15. Zeng YC, Li MJ, Chen Y, Jiang L, Wang SM, Mo XL, et al. The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis. Adv Med Sci 2014;59:95-101.
16. Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis. Am J Obstet Gynecol 2010;203:457.e1-9.
17. Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PloS One 2013;8:e64585.
18. Su DF, Wang XY. Metformin vs insulin in the management of gestational diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract 2014;104:353-7.
19. Higgins JPT, Altman DG, Sterne JAC, eds. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 . Cochrane Collaboration, 2011. www.cochrane-handbook.org.
20. Silva JC, Bertini AM, Taborda W, Becker F, Bebber FR, Aquim GM, et al. [Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin]. Arq Bras Endocrinol Metabol 2007;51:541-6.
21. Anjalakshi C, Balaji V, Balaji MS, Seshiah V. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract 2007;76:474-5.
22. Ogunyemi D, Jesse M, Davidson M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract 2007;13:427-8.
23. Mukhopadhyay P, Bag TS, Kyal A, Saha DP, Khalid N. Oral hypoglycemic glibenclamide: can it be a substitute to insulin in the management of gestational diabetes mellitus? A comparative study. J SAFOG 2012;4:28-31.
24. Tempe A, Mayanglambam RD. Glyburide as treatment option for gestational diabetes mellitus. J Obstet Gynaecol Res 2013;39:1147-52.
25. Moore LE, Briery CM, Clokey D, Martin RW, Williford NJ, Bofill JA et al. Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. J Reprod Med 2007;52:1011-5.
26. Ijas H, Vaarasmaki M, Morin-Papunen L, Keravuo R, Ebeling T, Saarela T, et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG 2011;118:880-5.
27. Niromanesh S, Alavi A, Sharbaf FR, Amjadi N, Moosavi S, Akbari S. Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. Diabetes Res Clin Pract 2012;98:422-9.
28. Tertti K, Ekblad U, Koskinen P, Vahlberg T, Ronnemaa T. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes Metab 2013;15:246-51.
29. Spaulonci CP, Bernardes LS, Trindade TC, Zugaib M, Francisco RP. Randomized trial of metformin vs insulin in the management of gestational diabetes. Am J Obstet Gynecol 2013;209:34.e1-7.
30. Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet Gynecol 2010;115:55-9.
31. Bennett WL, Robinson KA, Saldanha IJ, Wilson LM, Nicholson WK. High priority research needs for gestational diabetes mellitus. J Womens Health 2012;21:925-32.
32. Waugh N, Royle P, Clar C, Henderson R, Cummins E, Hadden D, et al. Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee. Health Technol Assess 2010;14:1-183.
33. Elliott BD, Langer O, Schenker S, Johnson RF. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 1991;165:807-12.
34. Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, et al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 2009;85:607-14.
35. Siega-Riz AM, Siega-Riz AM, Laraia B. The implications of maternal overweight and obesity on the course of pregnancy and birth outcomes. Maternal Child Health J 2006;10(5 suppl):S153-6.
36. Garcia-Patterson A, Aulinas A, Maria MA, Ubeda J, Orellana I, Ginovart G, et al. Maternal body mass index is a predictor of neonatal hypoglycemia in gestational diabetes mellitus. J Clin Endocrinol Metab 2012;97:1623-8.
37. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82.
38. Vanky E, De Zegher F, Diaz M, Ibanez L, Carlsen SM. On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome - an epi-analysis. Acta Obstet Gynecol Scand 2012;91:1460-4.